Clinical Trial Update: Pilot Study of X-82 in Patients With Wet AMD [Phase 1, Phase 2]

View source ↗

Summary

Pilot study results for X-82 in wet age-related macular degeneration (exudative AMD) across Phase 1 and Phase 2 have been posted after trial completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Exudative Macular Degeneration

Drugs mentioned

• X-82

Snippet

Sponsor: Tyrogenex | Conditions: Exudative Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-06-27